Cytokinetics CYTK Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies
Other financials
Where this comes from
Reported directly by Cytokinetics in its filing.
Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.
The official record: Cytokinetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytokinetics's comprehensive income (loss), net of tax, attributable to parent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytokinetics's comprehensive income (loss), net of tax, attributable to parent?
- Cytokinetics (CYTK) reported comprehensive income (loss), net of tax, attributable to parent of -$208.27M in Q1 2026.
- How has Cytokinetics's comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
- Cytokinetics's comprehensive income (loss), net of tax, attributable to parent decreased by 28.4% year-over-year, from -$162.23M to -$208.27M.
- What is the long-term trend for Cytokinetics's comprehensive income (loss), net of tax, attributable to parent?
- Over 4 years (2021 to 2025), Cytokinetics's comprehensive income (loss), net of tax, attributable to parent has grown at a 38.1% compound annual growth rate (CAGR), from -$216.33M to -$786.72M.
- What does comprehensive income (loss), net of tax, attributable to parent mean?
- The total change in company value from all sources, including profit and market fluctuations.
- How do you interpret comprehensive income (loss), net of tax, attributable to parent?
- A higher value indicates an overall increase in the company's net worth from all financial activities.
- How does comprehensive income (loss), net of tax, attributable to parent compare across companies?
- Standard financial reporting metric used to show total comprehensive performance beyond just net income.